Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

European Union (EU) pharmaceutical legislation known as the Clinical Trials Regulation entered into application on 31 January 2022. It aims to ensure the EU offers an attractive and favourable environment for carrying out clinical research on a large scale, with high standards of public transparency and safety for clinical trial participants. 

On 31 January 2022, the Regulation repealed the Clinical Trials Directive (EC) No. 2001/20/EC and national implementing legislation in the EU Member States, which regulated clinical trials in the EU until the Regulation's entry into application.

A transition period applies to clinical trial submission under the Regulation.

Table of Contents

Glossary

Disclaimer

1. Legal requirement

2. Scope

3. How to report a serious breach

4. Clarification on reporting requirements

5. Reporting serious breaches – Points to consider

6. Responsibilities of parties involved in the notification of a serious breach

7. General considerations for serious breaches

8. Possible actions taken by the EU/EEA Member States concerned (MSC)

9. References

Appendix I – Examples of serious breaches

Appendix II – Points to consider for sponsors in relation to the assessment of a breach

Appendix III a – Template form for reporting serious breaches

Appendix III b – Information to be submitted with a notification of a serious breach

 

Source: Medicines & Healthcare products Regulatory Agency, the UK.

Clinical Research News

The 'Hidden' Cholesterol Diet Can't Fix: New Drug to Be Tested on Heart Artery Plaque
The 'Hidden' Cholesterol Diet Can't Fix: New Drug to Be Tested on Heart Artery Plaque
When a Migraine Pill Doesn't Fully Work: Pfizer to Test Rimegepant Redosing
Psilocybin for Parkinson’s: Scientists Are Testing a Depression Treatment, Not a 'Magic Mushroom' Cure
When GLP-1 Fails: Novo Nordisk Explores a Different Path for Weight Management
Menopause Hot Flashes May Be More Than Just 'Heat': A Well-Known Drug to Be Tested for Vascular and Memory Links
Beyond Hormones: A New GLP-1 Drug Enters Early Trials for PCOS

Közelgő klinikai vizsgálatok

Clinical Research Jobs

More jobs

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

Iratkozz fel